- Home
- VIRC vs CTNM Comparison
VIRC vs CTNM Comparison
Compare VIRC & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRC
- CTNM
- Stock Information
- Founded
- VIRC 1950
- CTNM 2009
- Country
- VIRC United States
- CTNM United States
- Employees
- VIRC N/A
- CTNM N/A
- Industry
- VIRC Industrial Specialties
- CTNM
- Sector
- VIRC Consumer Discretionary
- CTNM
- Exchange
- VIRC Nasdaq
- CTNM Nasdaq
- Market Cap
- VIRC 131.1M
- CTNM 122.9M
- IPO Year
- VIRC N/A
- CTNM 2024
- Fundamental
- Price
- VIRC $7.92
- CTNM $3.92
- Analyst Decision
- VIRC
- CTNM Strong Buy
- Analyst Count
- VIRC 0
- CTNM 4
- Target Price
- VIRC N/A
- CTNM $22.50
- AVG Volume (30 Days)
- VIRC 80.9K
- CTNM 217.5K
- Earning Date
- VIRC 09-08-2025
- CTNM 08-12-2025
- Dividend Yield
- VIRC 1.26%
- CTNM N/A
- EPS Growth
- VIRC N/A
- CTNM N/A
- EPS
- VIRC 1.25
- CTNM N/A
- Revenue
- VIRC $253,259,000.00
- CTNM N/A
- Revenue This Year
- VIRC $0.81
- CTNM N/A
- Revenue Next Year
- VIRC $4.56
- CTNM N/A
- P/E Ratio
- VIRC $6.37
- CTNM N/A
- Revenue Growth
- VIRC N/A
- CTNM N/A
- 52 Week Low
- VIRC $7.79
- CTNM $3.35
- 52 Week High
- VIRC $18.50
- CTNM $21.92
- Technical
- Relative Strength Index (RSI)
- VIRC 42.75
- CTNM N/A
- Support Level
- VIRC $7.79
- CTNM N/A
- Resistance Level
- VIRC $8.41
- CTNM N/A
- Average True Range (ATR)
- VIRC 0.31
- CTNM 0.00
- MACD
- VIRC 0.00
- CTNM 0.00
- Stochastic Oscillator
- VIRC 12.87
- CTNM 0.00
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.